1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Netherlands >
  5. Edwards Acquires Bmeye B.V.

M&A Deal Summary

Edwards Acquires Bmeye B.V.

On October 10, 2012, Edwards acquired medical products company Bmeye B.V. for 33M EUR

Acquisition Highlights
  • This is Edwards’ 6th transaction in the Medical Products sector.
  • This is Edwards’ 6th largest (disclosed) transaction.
  • This is Edwards’ 2nd transaction in the Netherlands.

M&A Deal Summary
Date 2012-10-10
Target Bmeye B.V.
Sector Medical Products
Buyer(s) Edwards
Deal Type Add-on Acquisition
Deal Value 33M EUR

Target

Bmeye B.V.

Amsterdam, Netherlands
BMEYE B.V., a privately held Dutch company that specializes in the development of non-invasive technology for advanced hemodynamic monitoring. BMEYE's technology provides continuous, real-time information to clinicians and can be used in the surgical, intensive care, emergency room and cardiology settings.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Edwards

Irvine, California, United States
Category Company
Founded 1958
Sector Medical Products
Employees15,800
Revenue 5.4B USD (2024)
DESCRIPTION
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.
Entrance to Edwards Lifesciences' corporate headquarters in Irvine, California.

Edwards is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. Edwards was founded in 1958 and is based in Irvine, California.

DEAL STATS #
Overall 9 of 15
Sector: Medical Products M&A 6 of 12
Type: Add-on Acquisition M&A Deals 4 of 9
Country: Netherlands M&A 2 of 2
Year: 2012 M&A 1 of 1
Size (of disclosed) 6 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-11 Embrella Cardiovascular

Wayne, Pennsylvania, United States

Embrella Cardiovascular, Inc., the developer of the Embrella Embolic Deflector System, which can be used during transcatheter heart valve procedures.

Buy $43M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-26 CardiAQ Valve Technologies

Irvine, California, United States

CardiAQ Valve Technologies, Inc. is a developer of a transcatheter mitral valve replacement system.

Buy $400M
Mergr

Solution for

Product

Company

Legal